Tag: UiPath

Browse our exclusive articles!

UiPath Emerges as Fourth-Largest Holding in Ark Invest, Cathie Wood’s ETFs

UiPath emerges as Ark Invest's fourth-largest holding, highlighting Cathie Wood's conviction in AI investment. Find out more about UiPath's growth potential and financial performance.

Potential AI Stocks To Watch Out For According to Cathie Wood

Investors eye AI stocks for significant returns after Nvidia's success. Cathie Wood's ARK fund focuses on UiPath, Teladoc, and Twilio. All three companies have vast AI exposure and are trading at rare discounts.

Title: 3 Artificial Intelligence Stocks Show Growth in Options Trading In the world of investment, 3 companies focused on artificial intelligence have been gaining...

C3.ai, Palantir, and UiPath are three stocks benefiting from AI hype. Nvidia recently joined the $1tn market cap milestone for tech stocks. Options traders are paying attention.

Cathie Wood Trims Nvidia, Buys Significant Stake In Software Company UiPath While Wall Street Embraces AI Stocks

Cathie Wood, ARK Investment Management Founder & prominent investor, sold 65,600 shares of Chipmaker NVIDIA Corporation (NASDAQ: NVDA) worth near $25 million. Wood's ARK Innovation ETF closed out its entire NVIDIA stake in Jan. Wood has an eye for disruptive technologies like AI, robotics & 3D printing. Thursday, ARK Investment Management Invested $72 million in UiPath Inc. (NYSE: PATH).

60% of Workers Enhanced Job Fulfillment with AI-Assisted Automation – Report

Discover how AI-powered automation solutions can reduce burnout, elevate job satisfaction, and help workers in the new ‘automation generation’. According to a survey by UiPath, executives rely on automation solutions for data analysis, creating data, and more. 83% of those using automation reported improvement in job satisfaction. Get to know more!

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img